Allen & Overy (A&O) scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Allen & Overy increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. A&O forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. A&O does not publish a nondiscrimination policy. The company is recognized by Stonewall as a Top Global Employer for LGBTQ+ and implements unconscious bias training for its employees. The company has a reverse mentoring program and has hosted an LGBTQ+ initiative. A&O is Mansfield Certified, indicating its support of DEI in its recruitment, hiring, promotions, and leadership composition. The company is a partner of the Center for Reproductive Rights, building case law, advocating before policy makers, and engaging in litigation to challenge bans and restrictions on access to abortion. A&O is a member of the MCCA, indicating its focus on recruiting, retaining, and promoting employees based on race. The company is a part of the Law Firm Antiracism Alliance, committed to work on initiatives that fight “systemic racism”. For these reasons, A&O receives a High Risk rating.